At the Federal Scientific and Clinical Center of Medical Radiology and Oncology of Russia in Dimitrovgrad, the first patients underwent successful radionuclide therapy using a radiopharmaceutical drug based on lutetium-177. The drug was developed with the participation of specialists from the Research Institute of Nuclear Reactors, a long-time partner of USU.

In 2005, the Scientific and Educational Center for Radiation Technologies, as well as the consortium "USU - NIIAR" was formed on the basis of  Research Institute of Atomic Reactors and USU. This made it possible to combine efforts to develop and implement advanced high-tech technologies in the field of atomic science and technology, materials science, nuclear medicine, ecology and radiation physics.

Scientific directions developed on the basis of cooperation between the university and the Institute of Nuclear Reactors become the topics of candidate and doctoral dissertations of graduates of USU. Dozens of university students, thanks to the interaction of the two organizations, have already made a successful career in the nuclear industry, and this brilliant prospect awaits current physics students